Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Higher Dose Tamoxifen in Premenopausal Breast Cancer Patients: Preoperative Window Trial
KCT0006681Phase 2Active, not recruiting
- Sponsor
- Kwang Dong Pharmaceutical Co., Ltd.
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of tamoxifen in breast cancer, sponsored by Kwang Dong Pharmaceutical Co., Ltd. Started Oct 2021; status: active, not recruiting.
02
Drugs
tamoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on KCT0006681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0006681.